reports
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
S&P 500 and Nasdaq 100 Testing Prior 2022 Highs Since late-February (2/25/25 Compass) we expected an 8-10% pullback to provide a buying opportunity. But that all changed in last week's Compass (4/1/25), when we downgraded our outlook to bearish/cautious, citing several concerning developments (SPX and QQQ failure at 200-day MAs, bear flag breakdowns across major indexes targeting 5100-5200 on SPX, high yield spreads widening above 355bps, major tops on market leaders NVDA and META, semiconducto...
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
S&P 500 Holding Above Prior Breakout Level Yet Again As discussed throughout the first half of January, we continue to believe that tariffs will mostly be used as a negotiation tactic, and much like Trump's prior presidency, will be much less impactful than feared. We reiterated this in yesterday's pre-market ETF Pathfinder, also noting "we anticipate the Canada/Mexico tariffs to be resolved relatively quickly, and therefore we view the latest pullback as a buying opportunity." Sure enough, bot...
NTRA NATERA
MMSI MERIT MEDICAL SYSTEMS INC.
MDT MEDTRONIC PLC
LINC LINCOLN EDUCATIONAL SERVICES
FMS FRESENIUS MEDICAL CARE AG & CO. KGAA ADS
BMY BRISTOL-MYERS SQUIBB COMPANY
APEI AMERICAN PUBLIC EDUCATION
BSX. BELO SUN MINING CORP.
PEN PANORO ENERGY ASA
UTI UNIVERSAL TECHNICAL INSTITUTE INC.
LAUR LAUREATE EDUCATION INC. CLASS A
ATGE ADTALEM GLOBAL EDUCATION INC.
DGS. DIVIDEND GROWTH SPLIT
GH GUARDANT HEALTH
STRA STRATEGIC EDUCATION INC.
LRN STRIDE INC
LH LABCORP HOLDINGS INC
GSK GSK PLC
PROD PROSVETNO DELO AD ORD
An unfavourable environment weighs on NATERA, which sees a downgrade t...
The independent financial analyst theScreener just requalified the general evaluation of NATERA (US), active in the Medical Equipment industry. As regards its fundamental valuation, the title still shows 0 out of 4 stars and its market behaviour is seen as risky. theScreener believes that the unfavourable environment weighs on the sector and penalises the company, which sees a downgrade to its general evaluation to Negative. As of the analysis date January 11, 2022, the closing price was USD 76....
- Dave Nicoski
- Ross LaDuke
1A80 ACCELERATE DIAGNOSTICS INC.
MMM 3M COMPANY
ITW ILLINOIS TOOL WORKS INC.
BLUE BLUEBIRD BIO INC.
ZIOP ZIOPHARM ONCOLOGY INC.
VMC VULCAN MATERIALS COMPANY
SPKE SPARK ENERGY INC-CLASS A
SF STIFEL FINANCIAL CORP.
PDFS PDF SOLUTIONS INC.
PBYI PUMA BIOTECHNOLOGY INC.
NVR NVR INC.
NTRA NATERA
MTH MERITAGE HOMES CORPORATION
MKSI MKS INSTRUMENTS INC.
LRCX LAM RESEARCH CORPORATION
LGIH LGI HOMES INC.
HIBB HIBBETT SPORTS INC.
FCX FREEPORT-MCMORAN INC.
DBD DIEBOLD NIXDORF INCORPORATED
CPB CAMPBELL SOUP COMPANY
CL COLGATE-PALMOLIVE COMPANY
CB CHUBB LIMITED
CAR AVIS BUDGET GROUP INC.
BRX BRIXMOR PROPERTY GROUP INC.
BEN FRANKLIN RESOURCES INC.
BCOR BLUCORA INC.
AMAT APPLIED MATERIALS INC.
ALXN ALEXION PHARMACEUTICALS INC.
ACAD ACADIA PHARMACEUTICALS INC.
CETV CENTRAL EUROPEAN MEDIA ENTERPRISES LTD. CL A
DHI D.R. HORTON INC.
AMWD AMERICAN WOODMARK CORPORATION
BLD TOPBUILD CORP.
CMO CAPSTEAD MORTGAGE CORPORATION
CRI CARTER'S INC.
CRUS CIRRUS LOGIC INC.
UEIC UNIVERSAL ELECTRONICS INC.
SJM J.M. SMUCKER COMPANY
MHO M/I HOMES INC.
PLSE PULSE BIOSCIENCES
BF.A BROWN-FORMAN CORP. CL A
SCO PROSHARES ULTRASHORT BLOOMBERG
ICHR ICHOR HOLDINGS LTD.
FND FLOOR & DECOR HOLDINGS INC. CLASS A
GDI GARDNER DENVER HOLDINGS
CLXT CALYXT
WTTR SELECT ENERGY SERVICES INC. CLASS A
AMKR AMKOR TECHNOLOGY INC.
APLS APELLIS PHARMACEUTICALS
SWCH SWITCH
LEN.B LENNAR CORP. CL B
- Dave Nicoski
- Ross LaDuke
Vermilion Compass: Weekly Equity Strategy
As higher lows continue within a broader YTD sideways consolidation, the S&P 500 is poised to retest the 2,790-2,800 horizontal resistance level that we have highlighted in previous reports. While we continue to expect the broad YTD consolidation to continue, below we highlight additional factors that lead to our overall constructive outlook: • XLF bouncing off critical support with authority. We have voiced our concern regarding a potential breakdown below $26.50 on the XLF and the negativ...
SYY SYSCO CORPORATION
PRAH PRA HEALTH SCIENCES INC.
PFGC PERFORMANCE FOOD GROUP COMPANY
NTRA NATERA
NEO NEOGENOMICS INC.
2M9 MEDIDATA SOLUTIONS INC.
LH LABORATORY CORPORATION OF AMERICA HOLDINGS
LFUS LITTELFUSE INC.
KEM KEMET CORPORATION
ICLR ICON PLC
DGX QUEST DIAGNOSTICS INCORPORATED
ARWR ARROWHEAD PHARMACEUTICALS INC.
MEDP MEDPACE HOLDINGS INC.
CTS CTS CORP.
VSH VISHAY INTERTECHNOLOGY INC.
USFD US FOODS HOLDING CORP.
APRN BLUE APRON HOLDINGS
SVU SUPERVALU INC.
TTDKY TDK CORP. ADS
Large Study Shows Natera’s Panorama Prenatal Screen To Be Highly Acc...
SAN CARLOS, Calif.--(BUSINESS WIRE)-- Natera, Inc. (NASDAQ: NTRA), a leader in non-invasive genetic testing and the analysis of circulating cell-free DNA, today announced the publication of a large clinical experience study evaluating the performance of the company’s Panorama® non-invasive prenatal test (NIPT). The study, published in Clinical Genetics, retrospectively analyzed the performance of the single-nucleotide polymorphism (SNP)-based NIPT in 80,449 referrals for 22q11.2 deletion syndrome and 42,326 refe...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.